Synonyms:
Triple G
Molecular Formula:
C₂₂₁H₃₄₂N₄₆O₆₈
Form:
Prefilled Pen
Raw material
USA
Country of origin
UAE
Purity
99%
Obesity
Excess body weight
Insulin resistance
Metabolic syndrome
Impaired glucose regulation
Difficulty achieving weight reduction through conventional approaches
Hypersensitivity to Retata or formulation components
Pregnancy
Breastfeeding
Significant gallbladder or biliary disease
Severe hepatic impairment
Severe renal impairment
Retata for Weight Management
Unlike compounds that target a single metabolic pathway, Retata acts as a triple agonist. By engaging GLP-1, GIP, and glucagon receptors simultaneously, it may provide broader metabolic support and is being investigated for its potential role in obesity management and body-weight control.
The combined mechanism may help reduce calorie intake by supporting earlier and longer-lasting satiety while also influencing energy utilization. Its glucagon-receptor activity adds another metabolic pathway associated with energy expenditure and lipid metabolism.
Retata has attracted significant interest in metabolic medicine because of this three-pathway approach and its potential to produce substantial changes in body weight and metabolic markers.